Abstract：
:To determine if the carcinogenic potential of peroxisome proliferators is dependent upon their ability to induce cell proliferation, we have investigated the extent of cell proliferation in the livers of rats fed ciprofibrate, a peroxisome proliferator. Male rats were maintained on a diet containing ciprofibrate (0.025% w/w) and killed at selected intervals following 1 week of continuous [3H]thymidine labeling. Evaluation of labeling indices demonstrated a significant increase in cell proliferation during the first week but not in rats killed at the end of 5 and 20 weeks of treatment. Increases in hepatocyte nuclear labeling were found at 40 and 70 weeks of ciprofibrate administration which coincided with the appearance in livers of putative preneoplastic and neoplastic lesions. In a short-term feeding study, ciprofibrate and ethoxyquin were fed to rats at a dietary concentration of 0.025% and 0.5%, respectively, either alone or in combination for 7 days. Ciprofibrate and ethoxyquin either alone or in combination produced marked hepatomegaly and a significant increase in DNA synthesis as demonstrated by [3H]thymidine incorporation and autoradiographic studies. DNA synthesis in the group receiving ciprofibrate and ethoxyquin simultaneously, was slightly more than in animals that received either compound alone, suggesting a synergistic effect, although chronic feeding of these agents together resulted in inhibition of liver carcinogenesis (Rao, M. S. et al. (1984) Cancer Res., 44, 1072-1076). The results of this study further suggest that cell proliferation induced by peroxisome proliferators may be less important in carcinogenesis than peroxisome proliferation induced by these compounds.
journal_name
Cancer Lettjournal_title
Cancer lettersauthors
Yeldandi AV,Milano M,Subbarao V,Reddy JK,Rao MSdoi
10.1016/0304-3835(89)90172-9subject
Has Abstractpub_date
1989-09-15 00:00:00pages
21-7issue
1-2eissn
0304-3835issn
1872-7980pii
0304-3835(89)90172-9journal_volume
47pub_type
杂志文章相关文献
CANCER LETTERS文献大全abstract：:Non-small cell lung cancer (NSCLC) patients with activating EGFR mutations are often successfully treated with EGFR tyrosine kinase inhibitor (TKI) such as erlotinib; however, treatment resistance inevitably occurs. Given tumor metabolism of glucose and therapeutic response are intimately linked, we explored the metab...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2018.07.025
更新日期：2018-10-10 00:00:00
abstract：:We have evaluated the frequency of HLA class I and II antigens in 205 Italian patients with hepatocellular carcinoma (HCC) and 749 blood donors (controls). Moreover, we have looked for correlations between HLA antigen frequencies and HBV and/or HCV infections in HCC patients. We found great differences in HLA antigen ...
journal_title：Cancer letters
pub_type： 杂志文章
doi：
更新日期：1995-11-27 00:00:00
abstract：:We analyzed TP53 codon 72 polymorphism, HPV DNA in 32 subjects with oesophageal cancer and 57 healthy subjects with normal oesophageal cytology from an area of China with a high prevalence for this cancer (Linxian County, Henan Province). The frequency of the proline allele (0.63) was significantly higher in the Chine...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(00)00643-1
更新日期：2001-01-26 00:00:00
abstract：:BRAFV600- and MEK1/2-targeting therapies rarely produce durable response in melanoma patients. We investigated five BRAFV600E melanoma cell lines derived from drug-naïve tumor specimens to assess cell death response to encorafenib (Braftovi), a recently FDA-approved BRAFV600 inhibitor. Drug-naïve cell lines (i) did no...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2020.11.036
更新日期：2021-02-28 00:00:00
abstract：:Lysophosphatidic acid (LPA) receptors including LPA(1), LPA(2), and LPA(3) mediate lysophosphatidic acid signals. We analyzed the expression of LPA receptors, vascular endothelial growth factor (VEGF), and interleukin-8 in 97 patients from normal ovary to ovarian cancer, using reverse transcription polymerase chain re...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(02)00713-9
更新日期：2003-03-31 00:00:00
abstract：:Iron-enriched diets caused an increase of tumor rate in two models of dimethylhydrazine(DMH)-induced colon tumorigenesis in mice. The effect was independent of the time the iron-diet was fed, i.e. during DMH-treatment or following the DMH-treatment period. The increase of tumor rate depended on the iron concentration ...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(92)90239-r
更新日期：1992-08-31 00:00:00
abstract：:We reported that poor prognoses of hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA) are owing to up-regulation of expression of hypoxia-inducible factor-1 and epithelial cell adhesion molecule. We investigated aggressive progression in residual liver tumors (RLTs) after RFA to focus on expre...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2016.02.041
更新日期：2016-05-28 00:00:00
abstract：:SENCAR mice have been selectively bred for hypersusceptibility to 2-stage chemical skin carcinogenesis. In this study the relative susceptibilities of SENCAR, BALB/c and CD-1 mice to systemic carcinogenesis by N-nitrosohexamethyleneimine (NHEX) were examined. NHEX was administered twice weekly (1 mg/mouse) in corn oil...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(88)90110-3
更新日期：1988-08-15 00:00:00
abstract：:DNA methylation of the CpG-rich 5' region of the deoxycytidine kinase (dCK) gene is potentially involved in the suppression of the gene and the resistance of tumour cells to arabinosylcytosine (ara-C). 2-Chlorodeoxyadenosine (cladribine, CdA) and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA) are purine nucleosi...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(98)00131-1
更新日期：1998-08-14 00:00:00
abstract：:Receptors for all classes of steroid hormones were identified in cytosols of adenocarcinoma of the lung. In contrast, the incidence of receptor in squamous cell carcinoma was limited and small cell carcinomas appeared devoid of receptor. Receptor binding was of high affinity, saturable and localized to the 8, 6-7 and ...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(82)90014-3
更新日期：1982-09-01 00:00:00
abstract：:Women who have breast cysts with intracystic Na+/K+ < 3 may have a higher risk of developing breast cancer than women who have breast cysts with intracystic Na+/K+ > 3. In this study wide-ranging intracystic concentrations of cathepsin D and pS2 (oestrogen inducible proteins/polypeptides) as well as oestradiol were fo...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(93)90027-7
更新日期：1993-04-15 00:00:00
abstract：:In vitro cytotoxicity tests currently in use applied in the developmental stages of anticancer drug discovery are able to select the most potent compounds, but are not predictive of their potential toxicity. In this study, we have demonstrated the applicability of neutral red uptake assay using mouse fibroblasts Balb/...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2005.01.014
更新日期：2005-11-08 00:00:00
abstract：:Epstein-Barr virus (EBV) has been well documented in the aetiology of nasopharyngeal carcinoma (NPC), although its role as well as the genetic basis in the genesis of NPC have not been elucidated. The p53 gene mutations are infrequently found in NPC, but the expression of p53 protein, as well as bcl-2 oncoprotein, has...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(00)00582-6
更新日期：2000-11-28 00:00:00
abstract：:Circular RNAs (circRNAs) are a class of non-coding RNAs that do not have 5' end caps or 3' end poly (A) tails. There are more than one hundred thousand genes that encode circRNAs. Clinical data show that there are differences in the expression of circRNAs in a variety of diseases, including cancer, suggesting that cir...
journal_title：Cancer letters
pub_type： 杂志文章,评审
doi：10.1016/j.canlet.2018.03.035
更新日期：2018-07-01 00:00:00
abstract：:Control of E2F1 activity is restricted via its interactions with RB1 and HDAC1. However, the detailed regulatory mechanisms underlying the E2F1/HDAC1 complex remain elusive. Here, we report that Nemo-like kinase (NLK) boosts cell cycle progression, which facilitates tumor development by releasing the E2F1 protein from...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2018.05.032
更新日期：2018-09-01 00:00:00
abstract：:Fanconi anemia (FA) is a rare genome instability syndrome characterized by progressive bone marrow failure and predisposition to cancer, especially head and neck squamous cell carcinoma. Surgical resection is the standard of care for solid tumors, as patients with FA do not tolerate genotoxic chemotherapies or radiati...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2019.12.008
更新日期：2020-03-01 00:00:00
abstract：:Helicobacter pylori (H. pylori) infection is considered a major risk factor for gastric cancer. CagA behaves as a major bacterial oncoprotein playing a key role in H. pylori-induced tumorigenesis. Cancer stem cells (CSCs) are believed to possess the ability to initiate tumorigenesis and promote progression. Although s...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2016.02.032
更新日期：2016-05-01 00:00:00
abstract：:Since CP always exists in aqueous solution as a mixture of native drug and various aqua and hydroxo species, it is conceivable that one or more of these aquated species is the main form of the drug that enters the cell. To test this hypothesis, we examined the accumulation by 2008 human ovarian carcinoma cells of CP a...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(94)90205-4
更新日期：1994-06-30 00:00:00
abstract：:Potassium bromate (KBrO(3)) is a rat renal carcinogen and a major drinking water disinfection by-product in water disinfected with ozone. Clear cell renal tumors, the most common form of human renal epithelial neoplasm, are rare in animals but are inducible by KBrO(3) in F344 rats. Detection of cytoplasmic periodic ac...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(02)00407-x
更新日期：2002-12-10 00:00:00
abstract：:Present studies show the in vitro addition of glutathione (GSH) can significantly alter selenite induced growth inhibition of mammary tumor cell line 13 (CMT-13). Preincubation with 100 microM GSH for 24 h partially prevented the growth inhibition caused by 12.6 microM selenite. Pre-incubation with 100 microM GSH for ...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(91)90213-2
更新日期：1991-05-01 00:00:00
abstract：:Cancers of the gastrointestinal (GI) tract continue to represent a major health problem, despite progress in therapy. Gut microbiota is a key element related to the genesis of GI cancers, countless papers addressing this burning issue across the world. We provide an updated knowledge of the involvement of gut microbio...
journal_title：Cancer letters
pub_type： 杂志文章,评审
doi：10.1016/j.canlet.2013.08.013
更新日期：2014-04-10 00:00:00
abstract：:Sprague--Dawley rats, both intact and colostomized animals, were given 24 weekly injections of azoxymethane. Rats were fed either Rat Purina Chow or the same diet plus 0.25% disulfiram. In the intact animals, disulfiram reduced tumors from an average of 6.3 to 0.95. The number of rats developing tumors was reduced fro...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(78)80050-0
更新日期：1978-08-01 00:00:00
abstract：:The level of GSH in ovarian carcinoma cells which were sensitive and resistant to cisplatin was serially determined following tumor removal from the animals, in addition, activities of GSH-reductase and GSH-S-transferase were assessed. The GSH level in the resistant line (O-342/DDP) was almost twice as high as that in...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/0304-3835(89)90132-8
更新日期：1989-08-01 00:00:00
abstract：:Bevacizumab (Avastin®, Genentech, CA) was granted accelerated approval by the FDA for metastatic breast cancer in 2008. This occurred after the initial clinical trial, E2100, demonstrated an improvement in progression-free survival (PFS) and overall survival (OS) with the addition of bevacizumab to a standard chemothe...
journal_title：Cancer letters
pub_type： 杂志文章,评审
doi：10.1016/j.canlet.2014.10.028
更新日期：2015-02-01 00:00:00
abstract：:The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an important growth factor system involved in both the development of the organism and the maintenance of normal function of many cells of the body. The system also has powerful anti-apoptotic effects. More recently, evidence has...
journal_title：Cancer letters
pub_type： 杂志文章,评审
doi：10.1016/s0304-3835(03)00159-9
更新日期：2003-06-10 00:00:00
abstract：:Inhibition of angiogenesis provides a potential anti-cancer therapy. Here we describe a novel recombinant peptide composed of active fragments of two distinct angiogenesis inhibitors, platelet factor-4 (C-13 fragment) and vasostatin (N-terminal amino acids 135-164) with a nonpolar peptide bridge of Gly-Pro-Gly. This f...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2007.05.002
更新日期：2007-10-18 00:00:00
abstract：:We constructed the plasmid which can express human wild-type p53 cDNA and introduced it into the human osteosarcoma cell line SAOS-2 that lacks the chromosomal p53 gene. A cell clone stably expressing p53 protein was isolated and UV sensitivity and UV-induced mutation frequencies of the clone were examined. The UV sen...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/s0304-3835(97)00406-0
更新日期：1998-01-16 00:00:00
abstract：:Non-small cell lung cancer (NSCLC) remains one of the most metastasizing tumors, and directional cell migration is critical for targeting tumor metastasis. GIT2 has been known to bind to Paxillin to control cell polarization and directional migration. However, the molecular mechanisms underlying roles of GIT2 in contr...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2016.05.027
更新日期：2016-08-28 00:00:00
abstract：:Tumor acidity is now considered an important determinant of drug-resistance and tumor progression, and anti-acidic approaches, such as Proton Pump inhibitors (PPIs), have demonstrated promising antitumor and chemo-sensitizing efficacy. The main purpose of the present study was to evaluate the possible PPI-induced sens...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2014.10.017
更新日期：2015-01-28 00:00:00
abstract：:We investigated the role of the 5-lipoxygenase (5-LOX) pathway of arachidonic acid metabolism in tumour necrosis factor-alpha (TNF-alpha)-induced differentiation of human leukemic HL-60 cells using MK-886, an inhibitor of 5-LOX activating protein. MK-886 augmented cell cycle arrest and differentiation induced by TNF-a...
journal_title：Cancer letters
pub_type： 杂志文章
doi：10.1016/j.canlet.2005.06.012
更新日期：2006-06-18 00:00:00
